SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-19-001241
Filing Date
2019-01-25
Accepted
2019-01-25 16:32:55
Documents
3
Period of Report
2019-01-21
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM 8-K f8k012119a1_adialpharm.htm 8-K/A 20810
2 PRESS RELEASE OF ADIAL PHARMACEUTICALS, INC. DATED JANUARY 24, 2019 f8k012119a1ex99-1_adialpharm.htm EX-99.1 8677
3 GRAPHIC image_001.jpg GRAPHIC 3967
  Complete submission text file 0001213900-19-001241.txt   36485
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38323 | Film No.: 19542913
SIC: 2834 Pharmaceutical Preparations